Characterisation and clinical management of CPT-11 (irinotecan)-induced adverse events: the European perspective. [electronic resource]
Producer: 19961217Description: S18-23 p. digitalISSN:- 0959-8049
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.